DNA methylation profiles of lung tumors

Molecular Cancer Therapeutics

Volumn 1, Issue 1, 2001, Pages 61-67

  Toyooka, Shinichi ^a   Toyooka, Kiyomi O ^a   Maruyama, Riichiroh ^a   Virmani, Arvind K ^a,b   Girard, Luc ^a   Miyajima, Kuniharu ^a   Harada, Kenichi ^a   Ariyoshi, Yutaka ^c   Takahashi, Takashi ^c   Sugio, Kenji ^d   Brambilla, Elisabeth ^e   Gilcrease, Michel ^f   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CADHERIN; DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; ISOENZYME; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16INK4A; RASSF1 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BRONCHUS TUMOR; CARCINOID; COMPARATIVE STUDY; DNA METHYLATION; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL NEOPLASMS; CADHERINS; CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 17144434013     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA Cancer J. Clin., 51: 15-36, 2001. (Pubitemid 32166444)
2. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 80: 827-841, 1999. (Pubitemid 29108856)
3. Chute, J. P., Kelley, M. J., Venzon, D., Williams, J., Roberts, A., and Johnson, B. E. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer. Chest, 110: 165-171, 1996. (Pubitemid 26249319)
4. Wingo, P. A., Ries, L. A., Parker, S. L., and Heath, C. W., Jr. Long-term cancer patient survival in the United States, Cancer Epidemiol. Biomark. Prev., 7: 271-282, 1998. (Pubitemid 28354137)
5. Sekido, Y., Fong, K. M., and Minna, J. D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta, 1378: F21-F59, 1998. (Pubitemid 28381125)
6. Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., and Koss, M. N. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am. J. Surg. Pathol., 22: 934-944, 1998. (Pubitemid 28364493)
7. Onuki, N., Wistuba, I. I., Travis, W. D., Virmani, A. K., Yashima, K., Brambilla, E., Hasleton, P., and Gazdar, A. F. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer (Phila.), 85: 600-607, 1999. (Pubitemid 29075281)
8. Kovatich, A., Friedland, D. M., Druck, T., Hadaczek, P., Huebner, K., Comis, R. L., Hauck, W., and McCue, P. A. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer (Phila.), 83: 1109-1117, 1998. (Pubitemid 28419063)
9. Haruki, N., Yatabe, Y., Travis, W. D., Nomoto, S., Osada, H., Nakamura, S., Nakao, A., Fujii, Y., and Takahashi, T. Characterization of high-grade neuroendocrine tumors of the lung in relation to menin mutations. Jpn. J. Cancer Res., 91: 317-323, 2000. (Pubitemid 30198172)
10. Yuan, J., Knorr, J., Altmannsberger, M., Goeckenjan, G., Ahr, A., Scharl, A., and Strebhardt, K. Expression of p16 and lack of pRB in primary small cell lung cancer. J. Pathol., 189: 358-362, 1999. (Pubitemid 29489220)
11. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994.
12. Williams, C. L. Basic science of small cell lung cancer. Chest Surg. Clin. N. Am., 7: 1-19, 1997. (Pubitemid 27030144)
13. Girard, L., Zochbauer-Muller, S., Virmani, A. K., Gazdar, A. F., and Minna, J. D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res., 60: 4894-4906, 2000.
14. Virmani, A. K., Fong, K. M., Kodagoda, D., McIntire, D., Hung, J., Tonk, V., Minna, J. D., and Gazdar, A. F. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 21: 308-319, 1998. (Pubitemid 28165038)
15. Slebos, R. J., and Rodenhuis, S. The ras gene family in human non-small-cell lung cancer. Monogr. Natl. Cancer Inst., 13: 23-29, 1992.
16. Wistuba, I. I., Barry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., and Gazdar, A. F. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin. Cancer Res., 6: 2604-2610, 2000. (Pubitemid 30482094)
17. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998. (Pubitemid 27435555)
18. Costello, J. F., Fruhwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomaki, P., Lang, J. C., Schuller, D. E., Yu, L., Bloomfield, C. D., Caligiuri, M. A., Yates, A., Nishikawa, R., Su Huang, H., Petrelli, N. J., Zhang, X., O'Dorisio, M. S., Held, W. A., Cavenee, W. K., and Plass, C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24: 132-138, 2000. (Pubitemid 30094712)
19. Esteller, M., Corn, P. G., Baylin, S. B., and Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res., 61: 3225-3229, 2001. (Pubitemid 32695003)
20. Zochbauer-Muller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., and Minna, J. D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res., 61: 249-255, 2001. (Pubitemid 32095725)
21. Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., Minna, J. D., and Gazdar, A. F. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas. J. Natl. Cancer Inst. (Bethesda), 92: 1303-1307, 2000. (Pubitemid 30660589)
22. Toyooka, K. O., Toyooka, S., Virmani, A. K., Sathyanarayana, U. G., Euhus, D. M., Gilcrease, M., Minna, J. D., and Gazdar, A. F. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res., 61: 4556-4560, 2001. (Pubitemid 32685789)
23. Virmani, A. K., Rathi, A., Sathyanarayana, U. G., Padar, A., Huang, C. X., Cunnigham, H. T., Farinas, A. J., Milchgrub, S., Euhus, D. M., Gilcrease, M., Herman, J., Minna, J. D., and Gazdar, A. F. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res., 7: 1998-2004, 2001. (Pubitemid 32994838)
24. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. (Bethesda), 93: 691-699, 2001. (Pubitemid 32492810)
25. Toyooka, S., Pass, H. I., Shivapurkar, N., Fukuyama, Y., Maruyama, R., Toyooka, K. O., Gilcrease, M., Farinas, A., Minna, J. D., and Gazdar, A. F. Aberrant methylation and SV40 Tag sequences in malignant mesothelioma. Cancer Res., 61: 5727-5730, 2001. (Pubitemid 32769086)
26. Dammann, R., Takahashi, T., and Pfeifer, G. P. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene, 20: 3563-3567, 2001. (Pubitemid 32619409)
27. Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Jr., Carney, D., Minna, J. D., and Mulshine, J. L. NCI-Navy Medical Oncology Branch cell line data base. J. Cell Biochem. Suppl., 24: 32-91, 1996.
28. Herrmann, B. G., and Frischauf, A. M. Isolation of genomic DNA. Methods Enzymol., 152: 180-183, 1987. (Pubitemid 18025921)
29. Cote, S., Sinnett, D., and Momparler, R. L. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor β gene in human colon carcinoma cells. Anticancer Drugs, 9: 743-750, 1998. (Pubitemid 28512879)
30. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996. (Pubitemid 26296693)
31. Esteller, M., Corn, P. G., Urena, J. M., Gabrielson, E., Baylin, S. B., and Herman, J. G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res., 58: 4515-4518, 1998. (Pubitemid 28480605)
32. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., and Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem., 272: 22322-22329, 1997. (Pubitemid 27382868)
33. Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., and Herman, J. G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59: 793-797, 1999. (Pubitemid 29086728)
34. INK4A inactivation in non-small-cell lung cancers. Oncogene, 16: 497-504, 1998.
35. Kelley, M. J., Nakagawa, K., Steinberg, S. M., Mulshine, J. L., Kamb, A., and Johnson, B. E. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J. Natl. Cancer Inst. (Bethesda), 87: 756-761, 1995.
36. INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res., 61: 3419-3424, 2001.
37. Markl, I. D., Cheng, J., Liang, G., Shibata, D., Laird, P. W., and Jones, P. A. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res., 61: 5875-5884, 2001. (Pubitemid 32771343)
38. Auerbach, O., Stout, A. P., Hammond, E. C., and Garfinkel, L. Changes in bronchial epithelium in relation to smoking and cancer of the lung. N. Engl. J. Med., 265: 253-267, 1961.
39. Gazdar, A. F., and Minna, J. D. Cigarettes, sex, and lung adenocarcinoma. J. Natl. Cancer Inst. (Bethesda), 89: 1563-1565, 1997.
40. Travis, W. D., Travis, L. B., and Devesa, S. S. Lung cancer. Cancer (Phila.), 75: 191-202, 1995.
41. Tang, X., Khuri, F. R., Lee, J. J., Kemp, B. L., Liu, D., Hong, W. K., and Mao, L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J. Natl. Cancer Inst. (Bethesda), 92: 1511-1516, 2000.
42. Schwartsmann, G., Schunemann, H., Gorini, C. N., Filho, A. F., Garbino, C., Sabini, G., Muse, I., DiLeone, L., and Mans, D. R. A Phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early Phase II evaluation in patients with inoperable non-small cell lung cancer. Invest New Drugs, 18: 83-91, 2000. (Pubitemid 30175899)
43. Momparler, R. L., Eliopoulos, N., and Ayoub, J. Evaluation of an inhibitor of DNA methylation, 5-aza-2′-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy. Adv. Exp. Med. Biol., 465: 433-446, 2000. (Pubitemid 32193354)
44. Gazdar, A. F., Zochbauer-Moller, S., Virmani, A., Kurie, J., Minna, J. D., and Lam, S. Response re: promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas. J. Natl. Cancer Inst. (Bethesda), 93: 67-68, 2001.